Supplementary Figure 7 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Huanjie Shao,Kai Jing,Esraa Mahmoud,Haihong Huang,Xianjun Fang,Chunrong Yu

DOI: https://doi.org/10.1158/1535-7163.22498932

2023-01-01

Abstract:PDF - 1353KB, Supplementary Figure S7. Inactivation of AKT and/or ERK resulted in upregulation of Bim-L.

What problem does this paper attempt to address?

Supplementary Figure 6 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Huanjie Shao,Kai Jing,Esraa Mahmoud,Haihong Huang,Xianjun Fang,Chunrong Yu

DOI: https://doi.org/10.1158/1535-7163.22498935

2023-01-01

Abstract:PDF - 427KB, Supplementary Figure S6. Apigenin downregulated Mcl-1 expression at mRNA level.
Supplementary Figure 2 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Huanjie Shao,Kai Jing,Esraa Mahmoud,Haihong Huang,Xianjun Fang,Chunrong Yu

DOI: https://doi.org/10.1158/1535-7163.22498947.v1

2023-01-01

Abstract:PDF - 678KB, Supplementary Figure S2. Apigenin enhanced ABT-263-triggered cell death in colon cancer cells.
Supplementary Figure 3 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Huanjie Shao,Kai Jing,Esraa Mahmoud,Haihong Huang,Xianjun Fang,Chunrong Yu

DOI: https://doi.org/10.1158/1535-7163.22498944.v1

2023-01-01

Abstract:PDF - 186KB, Supplementary Figure S3. Colon cancer cell lines displayed variable basal levels of Mcl-1 protein.
Supplementary Figure Legend from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Huanjie Shao,Kai Jing,Esraa Mahmoud,Haihong Huang,Xianjun Fang,Chunrong Yu

DOI: https://doi.org/10.1158/1535-7163.22498926.v1

2023-01-01

Abstract:PDF - 101KB, Legends for Supplemental Figures 1-8.
Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of Abt-263

Huanjie Shao,Kai Jing,Esraa Mahmoud,Haihong Huang,Xianjun Fang,Chunrong Yu

DOI: https://doi.org/10.1158/1535-7163.mct-13-0066

2013-01-01

Molecular Cancer Therapeutics

Abstract:Abstract Apigenin is an edible plant-derived flavonoid that shows modest antitumor activities in vitro and in vivo. Apigenin treatment resulted in cell growth arrest and apoptosis in various types of tumors by modulating several signaling pathways. In the present study, we evaluated interactions between apigenin and ABT-263 in colon cancer cells. We observed a synergistic effect between apigenin and ABT-263 on apoptosis of colon cancer cells. ABT-263 alone induced limited cell death while upregulating expression of Mcl-1, a potential mechanism for the acquired resistance to ABT-263. The presence of apigenin antagonized ABT-263–induced Mcl-1 upregulation and dramatically enhanced ABT-263–induced cell death. Meanwhile, apigenin suppressed AKT and ERK activation. Inactivation of either AKT or ERK by lentivirus-transduced shRNA or treatment with specific small-molecule inhibitors of these pathways enhanced ABT-263–induced cell death, mirroring the effect of apigenin. Moreover, the combination response was associated with upregulation of Bim and activation of Bax. Downregulation of Bax eliminated the synergistic effect of apigenin and ABT-263 on cell death. Xenograft studies in SCID mice showed that the combined treatment with apigenin and ABT-263 inhibited tumor growth by up to 70% without obvious adverse effects, while either agent only inhibited around 30%. Our results demonstrate a novel strategy to enhance ABT-263–induced antitumor activity in human colon cancer cells by apigenin via inhibition of the Mcl-1, AKT, and ERK prosurvival regulators. Mol Cancer Ther; 12(12); 2640–50. ©2013 AACR.
Abstract 3290: Modulation of AKT, ERK and Mcl-1 by Apigenin Sensitizes Colon Cancer Cells to Anti-Tumor Activities of ABT263.

Huanjie Shao,Kai Jing,Esraa Mahmoud,Xianjun Fang,Chunrong Yu

DOI: https://doi.org/10.1158/1538-7445.am2013-3290

IF: 11.2

2013-01-01

Cancer Research

Abstract:Apigenin is an edible plant-derived flavonoid showing anti-tumor activities in vitro and in vivo. Pretreatment with apigenin resulted in cell growth arrest and/or apoptosis in various types of tumors via modulating multiple cell signaling pathways. In the present study, we evaluated interactions between apigenin and ABT263 in multiple colon cancer cell lines. We found that apigenin enhanced ABT263-induced apoptosis in colon cancer cells in a time- and dose-dependent manner. ABT263 alone only resulted in limited cell killing in association with upregulation of Mcl-1, a potential mechanism for acquired ABT263 resistance. Apigenin antagonized ABT263-induced Mcl-1 expression and dramatically enhanced ABT263-induced cell death. Apigenin also suppressed AKT and ERK activation. Inactivation of either AKT or ERK pathway by lentivirus-transduced shRNA or specific small molecule inhibitors synergized with ABT263 to induce cell death, reflecting that AKT and ERK pathways are apigenin targets. Moreover, the synergism between ABT263 and apigenin was associated with the upregulation of Bim and subsequent activation of Bax. Xenograft studies with HCT116 cells in SCID mice showed that the combination treatment with apigenin and ABT263 inhibited tumor growth up to 70% without obvious adverse effects, while either agent alone showed only about 30% inhibition. Collectively, our findings demonstrate a novel and effective strategy to treat colon cancer by combination of ABT263 and apigenin. The combined effect is mediated by apigenin downregulation of Mcl-1, Akt and ERK activities. Citation Format: Huanjie Shao, Kai Jing, Esraa Mahmoud, Xianjun Fang, Chunrong Yu. Modulation of AKT, ERK and Mcl-1 by apigenin sensitizes colon cancer cells to anti-tumor activities of ABT263. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 3290. doi:10.1158/1538-7445.AM2013-3290
Anti-proliferation and Chemo-Sensitization Effects of Apigenin on Human Lung Cancer Cells

Huan-yu Ren,Xiu-wen Tang

DOI: https://doi.org/10.3785/j.issn.1008-9292.2011.05.008

2011-01-01

Abstract:OBJECTIVE:To investigate the antitumor effect of apigenin on human lung cancer cells.METHODS:The anti-proliferation and sensitization effects of apigenin on human lung cancer cells was accessed by counting cells after Trypan blue staining and MTS assay.RESULTS:(1) Apigenin significantly suppressed the proliferation of four types of human lung cancer cells (A549:P=0.041, H460:P=0.050, LTEP-a2:P=0.039, H292:P=0.016); (2) Apigenin significantly increased the susceptibility of human lung cancer cells to antitumor drugs (P<0.05 or P<0.01) in a synergistic way (almost all of the combination index values are less than 1).CONCLUSION:Apigenin widely inhibits cell proliferation of various lung cancer cell lines in a dose-dependent manner and the combination treatment of apigenin and antitumor drugs is very effective in human lung cancer cells, and Nrf2-ARE pathway may contribute to the mechanism.
Supplementary Figure 2 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497784.v1

2023-01-01

Abstract:PDF file - 68K, Figure S2: Effect of BMS-777607 on breast cancer cell growth and apoptotic death.
BH3 Mimetic ABT-263 Enhances the Anticancer Effects of Apigenin in Tumor Cells with Activating EGFR Mutation

Yihong Zhan,Yue Wang,Miao Qi,Panpan Liang,Yu Ma,Ting Li,Hui Li,Congmei Dai,Zhifeng An,Yitao Qi,Hongmei Wu,Huanjie Shao

DOI: https://doi.org/10.1186/s13578-019-0322-y

2019-01-01

Cell & Bioscience

Abstract:BackgroundMutated epidermal growth factor receptor (EGFR) is one of the most successful targets in cancer targeted therapy. While this treatment has benefited many patients with an activating EGFR mutation (EGFRm), almost all those who initially benefited will eventually develop acquired drug resistance (ADR) after a certain period of time. New therapeutic strategies need to be explored to treat EGFRm tumors and overcome or minimize this recurring ADR.ResultsOur data showed that apigenin alone has only mild inhibitory effects on EGFRm tumor cells. By drug screening, we found that ABT-263 can significantly enhance the antitumor activities of apigenin in tumor cells harbouring an activating EGFR mutation and AZD9291-resistant H1975 cells. Mechanistically, apigenin upregulated the expression of Noxa in EGFRm tumor cells by targeting the AKT-FoxO3a pathway, thereby synergizing with ABT-263 to suppress tumor cell growth and proliferation in vitro and in vivo.ConclusionsOur study provides a rationale for the clinical application of the combination treatment of apigenin and BH3 mimetics in the treatment of EGFRm tumors.
Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong-Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming‐Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497787

2023-01-01

Abstract:PDF file - 63K, Figure S1: Expression of RON and MET by breast cancer MCF-7, T-47D and ZR-75-1 cells.
Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Tingyu Wu,Wei Chen,Yongwang Zhong,Xiaodan Hou,Shengyun Fang,Chen-Ying Liu,Guanghui Wang,Tong Yu,Yu-Yang Huang,Xuesong Ouyang,Henry Q.X. Li,Long Cui,Yili Yang

DOI: https://doi.org/10.1158/1535-7163.22507968.v1

2023-01-01

Abstract:Bortezomib and KPT330 co-treatment inhibit patients-derived xenografts in nude mice.
Supplementary Figure 3 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong-Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming‐Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497781

2023-01-01

Abstract:PDF file - 59K, Figure S3: Effect of PHA665752, Compound-I, and BMS-777607 on induction of polyploidy in breast cancer cells.
Supplementary Figure 2 from Inhibition of Mir-17 and Mir-20A by Oridonin Triggers Apoptosis and Reverses Chemoresistance by Derepressing BIM-S

Hengyou Weng,He Huang,Bo Dong,Panpan Zhao,Hui Zhang,Liang‐Hu Qu

DOI: https://doi.org/10.1158/0008-5472.22401543.v1

2023-01-01

Abstract:PDF file - 56KB, Overexpression of BIM induces apoptosis in K562 cells.
Supplementary Figure 1 from Dual Inhibition of PI3K and Mtor Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Xiaosong Chen,Mengmeng Zhao,Mingang Hao,Xueqing Sun,Jinglong Wang,Yan Mao,Lidong Zu,Junjun Liu,Yandong Shen,Jianhua Wang,Kunwei Shen

DOI: https://doi.org/10.1158/1541-7786.22510116

2023-01-01

Abstract:PDF file - 588K, Effects of single agent of tamoxifen, everolimus, or PI3K inhibitors (LY294002 or BKM120, BEZ-235) on MCF-7 and BT474 breast cancer cell lines after 48h and 72h treatment.
Supplementary Figure 1 from Ponatinib Induces Apoptosis in Imatinib-Resistant Human Mast Cells by Dephosphorylating Mutant D816V KIT and Silencing Β-Catenin Signaling

Bei Jin,Ke Ding,Jingxuan Pan

DOI: https://doi.org/10.1158/1535-7163.22501468.v1

2023-01-01

Abstract:PDF file - 134KB, The analysis of KIT mutation.
Supplementary Figure 6 from Inhibition of Mir-17 and Mir-20A by Oridonin Triggers Apoptosis and Reverses Chemoresistance by Derepressing BIM-S

Hengyou Weng,Huilin Huang,Bowen Dong,Panpan Zhao,Hui Zhou,Lianghu Qu

DOI: https://doi.org/10.1158/0008-5472.22401531.v1

2023-01-01

Abstract:PDF file - 45KB, Inhibition of miR-17 or miR-20a has little effect on the sensitivity of K562 to Ara-C.
Supplemental Fig.S4. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Tongzheng Liu,Yuan Fang,Haoxing Zhang,Min Deng,Bowen Gao,Nifang Niu,Jia Yu,SeungBaek Lee,JungJin Kim,Bo Qin,Fang Xie,Debra Evans,Liewei Wang,Wenhui Lou,Zhenkun Lou

DOI: https://doi.org/10.1158/0008-5472.22409682

2023-01-01

Abstract:<p>Supplemental Fig.S4. Akt inhibitor sensitizes pancreatic tumors with HEATR1 knockdown to gemcitabine.</p>
Supplementary Figure 4 from Ponatinib Induces Apoptosis in Imatinib-Resistant Human Mast Cells by Dephosphorylating Mutant D816V KIT and Silencing Β-Catenin Signaling

Bei Jin,Kun Ding,Jingxuan Pan

DOI: https://doi.org/10.1158/1535-7163.22500298

2023-01-01

Abstract:PDF file - 158KB, Peripheral blood cell counts of ASM/MCL mice.
Data Supplement from Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem–like Cells

Xiaokun Wang,Jun He,Jian Xu,Sheng Ye,Fang Wang,Hui Zhang,Zhen-cong Huang,Kenneth Kin Wah To,Liwu Fu

DOI: https://doi.org/10.1158/0008-5472.22402836

2023-01-01

Abstract:Supplementary Figure S4. A representative Western blot of the effect of afatinib on AKT and ERK 1/2 phosphorylation.
Supplemental Figures from Combined Menin and EGFR Inhibitors Synergize to Suppress Colorectal Cancer Via EGFR-Independent and Calcium-Mediated Repression of SKP2 Transcription

Bryson W. Katona,Rebecca A. Glynn,Kayla E. Paulosky,Zijie Feng,Caroline I. Davis,Jian Ma,Corbett T. Berry,Katherine M. Szigety,Smita Matkar,Yuanyuan Liu,Haoren Wang,Yuan Wu,Xin He,Bruce D. Freedman,Donita C. Brady,Xianxin Hua

DOI: https://doi.org/10.1158/0008-5472.22423937

2023-01-01

Abstract:Supplemental Figure S1: Menin inhibition has minimal effects on cell growth in colon cancer cells. Supplemental Figure S2: Inhibition of menin selectively sensitizes colon cancer cells to iEGFRs. Supplemental Figure S3: BAPTA rescues cells from the combination of gefitinib plus MI-2-2. Supplemental Figure S4: SERCA2 over-expression rescues cells from thapsigargin but not gefitinib. Supplemental Figure S5: Gefitinib induced CRC suppression is mediated by activation of IP3R3. Supplemental Figure S6: Menin inhibition, gefitinib, and TG all decrease SKP2 levels. Supplemental Figure S7: Regulation of SKP2 transcription by menin and intracellular calcium levels.

Supplementary Figure 7 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Supplementary Figure 6 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Supplementary Figure 2 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Supplementary Figure 3 from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Supplementary Figure Legend from Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of ABT-263

Apigenin Sensitizes Colon Cancer Cells to Antitumor Activity of Abt-263

Abstract 3290: Modulation of AKT, ERK and Mcl-1 by Apigenin Sensitizes Colon Cancer Cells to Anti-Tumor Activities of ABT263.

Anti-proliferation and Chemo-Sensitization Effects of Apigenin on Human Lung Cancer Cells

Supplementary Figure 2 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

BH3 Mimetic ABT-263 Enhances the Anticancer Effects of Apigenin in Tumor Cells with Activating EGFR Mutation

Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figure Legends from Nuclear Export of Ubiquitinated Proteins Determines the Sensitivity of Colorectal Cancer to Proteasome Inhibitor

Supplementary Figure 3 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figure 2 from Inhibition of Mir-17 and Mir-20A by Oridonin Triggers Apoptosis and Reverses Chemoresistance by Derepressing BIM-S

Supplementary Figure 1 from Dual Inhibition of PI3K and Mtor Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer

Supplementary Figure 1 from Ponatinib Induces Apoptosis in Imatinib-Resistant Human Mast Cells by Dephosphorylating Mutant D816V KIT and Silencing Β-Catenin Signaling

Supplementary Figure 6 from Inhibition of Mir-17 and Mir-20A by Oridonin Triggers Apoptosis and Reverses Chemoresistance by Derepressing BIM-S

Supplemental Fig.S4. from HEATR1 Negatively Regulates Akt to Help Sensitize Pancreatic Cancer Cells to Chemotherapy

Supplementary Figure 4 from Ponatinib Induces Apoptosis in Imatinib-Resistant Human Mast Cells by Dephosphorylating Mutant D816V KIT and Silencing Β-Catenin Signaling

Data Supplement from Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem–like Cells

Supplemental Figures from Combined Menin and EGFR Inhibitors Synergize to Suppress Colorectal Cancer Via EGFR-Independent and Calcium-Mediated Repression of SKP2 Transcription